Yarrow Bioscience, Inc. Common Stock

YARW

Market cap $20.3M

YARW Hedge Fund Activity: Q1 2026 in Review

42 of the 8,133 institutional investors tracked by Wall St. Rank reported a position in Yarrow Bioscience, Inc. Common Stock (YARW) for Q1 2026, worth a combined $8.63M — up 81% from $4.77M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new YARW positions and 5 closed out — a net gain of 2 holders — while 11 added to existing stakes and 3 trimmed.

The largest buyer was Lynx1 Capital Management, opening a new position worth an estimated $950K. The largest seller was Acadian Asset Management, cutting an estimated $150K.

• 42 institutional investors held Yarrow Bioscience, Inc. Common Stock (YARW) as of Q1 2026, up from 41 in Q4 2025.
• Funds reported $8.63M of Yarrow Bioscience, Inc. Common Stock stock for Q1 2026, up 81% quarter-over-quarter.
• 7 funds opened new Yarrow Bioscience, Inc. Common Stock positions in Q1 2026 and 5 closed out, a net change of +2 holders.
• The largest Yarrow Bioscience, Inc. Common Stock buyer in Q1 2026 was Lynx1 Capital Management, an estimated $950K added.
• The largest Yarrow Bioscience, Inc. Common Stock seller in Q1 2026 was Acadian Asset Management, an estimated $150K sold.

Based on aggregated 13F filings for Q1 2026.